87 related articles for article (PubMed ID: 6195654)
1. [Highly malignant non-Hodgkin's lymphoma. Treatment by intensive sequential chemotherapy].
Coiffier B; Bryon PA; Fière D; Felman P; Ffrench M; Rebattu P; Archimbaud E; Blanc M; Vuvan H; Guyotat D
Presse Med; 1983 Oct; 12(35):2159-62. PubMed ID: 6195654
[TBL] [Abstract][Full Text] [Related]
2. Intensive and sequential combination chemotherapy for aggressive malignant lymphomas (protocol LNH-80).
Coiffier B; Bryon PA; Berger F; Archimbaud E; Ffrench M; Extra JM; Guyotat D; Fiere D; Gentilhomme O; Magaud JP
J Clin Oncol; 1986 Feb; 4(2):147-53. PubMed ID: 2418166
[TBL] [Abstract][Full Text] [Related]
3. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
[TBL] [Abstract][Full Text] [Related]
4. Intensive treatment of stage III-IV aggressive malignant lymphomas (protocol TPL-84).
Colombat P; Guilhot F; Bordesoule D; Renou P; Benz-Lemoine E; Fouillard L; Drouet M; Tanzer J; Lamagnere JP
Haematologica; 1991; 76(6):479-84. PubMed ID: 1726492
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of primary mediastinal large B-cell lymphomas].
Schneider T; Tóth E; Molnár Z; Várady E; Deák B; Horváth A; Horváth GI; Eid H; Schneider K; Lovey J; Keresztes S; Esik O; Lengyel Z; Rosta A
Orv Hetil; 2004 Dec; 145(50):2531-7. PubMed ID: 15662753
[TBL] [Abstract][Full Text] [Related]
7. ProMACE-CytaBOM: combination chemotherapy for diffuse large cell lymphoma.
Prokocimer M; Modan M; Rusoshansky S; Bairey O; Shaklai M
Anticancer Res; 1989; 9(4):1233-5. PubMed ID: 2479327
[TBL] [Abstract][Full Text] [Related]
8. [Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma].
Kamieńska E
Ann Acad Med Stetin; 1996; 42():105-22. PubMed ID: 9199116
[TBL] [Abstract][Full Text] [Related]
9. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.
Fisher RI; Gaynor ER; Dahlberg S; Oken MM; Grogan TM; Mize EM; Glick JH; Coltman CA; Miller TP
N Engl J Med; 1993 Apr; 328(14):1002-6. PubMed ID: 7680764
[TBL] [Abstract][Full Text] [Related]
10. [Combination chemotherapy (modified CHOP-Bleo) in non-Hodgkin's lymphoma].
Hiruma K; Asai T; Aotsuka N; Hirasawa A; Wakita H; Endoh N; Nakamura H; Oh H; Yoshida S; Igarashi T
Gan To Kagaku Ryoho; 1990 Jan; 17(1):59-64. PubMed ID: 1688699
[TBL] [Abstract][Full Text] [Related]
11. Treatment of diffuse aggressive non-Hodgkin's lymphomas with an intensive multi-drug regimen including high-dose cytosine arabinoside (F-MACHOP).
Amadori S; Guglielmi C; Anselmo AP; Cimino G; Ruco LP; Papa G; Biagini C; Mandelli F
Semin Oncol; 1985 Jun; 12(2 Suppl 3):218-22. PubMed ID: 4012340
[No Abstract] [Full Text] [Related]
12. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
13. MACOP-B vs F-MACHOP in the treatment of high-grade non-Hodgkin's lymphomas.
Tura S; Mandelli F; Mazza P; Pileri S; Gherlinzoni F; Bocchia M; Zinzani PL; Fiacchini M; Martelli M; Papa G
Leukemia; 1991; 5 Suppl 1():74-8. PubMed ID: 1716338
[TBL] [Abstract][Full Text] [Related]
14. [Cyclophosphamide, adriamycin, vincristine, bleomycin and prednisolone (CHOP-Bleo) combination chemotherapy for advanced non-Hodgkin's lymphoma].
Sampi K; Honda T; Hattori M; Takayama S
Gan To Kagaku Ryoho; 1983 May; 10(5):1266-71. PubMed ID: 6191677
[TBL] [Abstract][Full Text] [Related]
15. HOAP-Bleo as salvage therapy for diffuse aggressive non-Hodgkin's lymphoma.
Liang R; Todd D; Chan TK
Cancer Chemother Pharmacol; 1988; 22(2):169-71. PubMed ID: 2457455
[TBL] [Abstract][Full Text] [Related]
16. A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL).
Gobbi PG; Ghirardelli ML; Avanzini P; Baldini L; Quarta G; Stelitano C; Broglia C; Loni C; Silingardi V; Ascari E
Haematologica; 2000 Mar; 85(3):263-8. PubMed ID: 10702814
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy. French-Italian Cooperative Group.
Gisselbrecht C; Oksenhendler E; Tirelli U; Lepage E; Gabarre J; Farcet JP; Gastaldi R; Coiffier B; Thyss A; Raphael M
Am J Med; 1993 Aug; 95(2):188-96. PubMed ID: 7689296
[TBL] [Abstract][Full Text] [Related]
18. [Non-Hodgkin's lymphomas: recent achievements and therapeutic perspectives].
Bron D; Vandenheule B; Stryckmans P
Rev Med Brux; 1985 Sep; 6(7):491-5. PubMed ID: 2417298
[No Abstract] [Full Text] [Related]
19. Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma.
Wilder RB; Rodriguez MA; Ha CS; Pro B; Hess MA; Cabanillas F; Cox JD
Cancer; 2001 Jun; 91(12):2440-6. PubMed ID: 11413536
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of non-Hodgkin's lymphomas with CHOP-bleo. Experience in 16 patients].
González Brito G; Marsá Vilá L; Chávez MI; Batista López N; Hernández Nieto L
Sangre (Barc); 1985; 30(3):367-8. PubMed ID: 2412301
[No Abstract] [Full Text] [Related]
[Next] [New Search]
